Moderna (MRNA) PT Lowered to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.67 +5.12%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Moderna (NASDAQ: MRNA) to $140.00 (from $145.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie
- Sumitomo Forestry Co (1911:JP) PT Lowered to JPY1,920 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
